Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mian

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Hematological Oncology|April 3, 2019
Frontline treatment of diffuse large B-cell lymphoma: Beyond R-CHOPPatrizia Mondello, Michael Mian
Critical Reviews in Oncology/Hematology|July 12, 2019
Primary central nervous system lymphoma: Novel precision therapiesPatrizia Mondello, Michael Mian, Francesco Bertoni
Journal of Hematology & Oncology|December 11, 2014
Pim kinases in hematological malignancies: where are we now and where are we going?Patrizia Mondello, Salvatore Cuzzocrea, Michael Mian
Oncotarget|December 15, 2015
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityrPatrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Clinical Lung Cancer|February 10, 2015
Cardiovascular Comorbidities and Events in NSCLC: Often Underestimated but Worth ConsideringFlorian Kocher, Michael Fiegl, Michael Mian, et al.
Springerplus|July 22, 2014
Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant diseasePatrizia Mondello, Michael Mian, Carmela Arrigo, et al.
Oncotarget|January 19, 2017
Bone marrow micro-environment is a crucial player for myelomagenesis and disease progressionPatrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Acta Haematologica|November 8, 2014
B cell lymphoma with lung involvement: what is it about?Michael Mian, Ines Wasle, Stefan Gritsch, et al.
Journal of Clinical Medicine|April 8, 2020
The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative IntentFlorian Kocher, Michael Mian, Andreas Seeber, et al.
Leukemia & Lymphoma|October 22, 2013
Rituximab: how evidence based medicine can change our clinical practiceMichael Mian, Stefan Gritsch, Ines Wasle, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Hematological Oncology|April 3, 2019
Frontline treatment of diffuse large B-cell lymphoma: Beyond R-CHOPPatrizia Mondello, Michael Mian
Critical Reviews in Oncology/Hematology|July 12, 2019
Primary central nervous system lymphoma: Novel precision therapiesPatrizia Mondello, Michael Mian, Francesco Bertoni
Journal of Hematology & Oncology|December 11, 2014
Pim kinases in hematological malignancies: where are we now and where are we going?Patrizia Mondello, Salvatore Cuzzocrea, Michael Mian
Oncotarget|December 15, 2015
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityrPatrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Clinical Lung Cancer|February 10, 2015
Cardiovascular Comorbidities and Events in NSCLC: Often Underestimated but Worth ConsideringFlorian Kocher, Michael Fiegl, Michael Mian, et al.
Springerplus|July 22, 2014
Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant diseasePatrizia Mondello, Michael Mian, Carmela Arrigo, et al.
Oncotarget|January 19, 2017
Bone marrow micro-environment is a crucial player for myelomagenesis and disease progressionPatrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Acta Haematologica|November 8, 2014
B cell lymphoma with lung involvement: what is it about?Michael Mian, Ines Wasle, Stefan Gritsch, et al.
Journal of Clinical Medicine|April 8, 2020
The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative IntentFlorian Kocher, Michael Mian, Andreas Seeber, et al.
Leukemia & Lymphoma|October 22, 2013
Rituximab: how evidence based medicine can change our clinical practiceMichael Mian, Stefan Gritsch, Ines Wasle, et al.
Pageof 10